Back
Cidara Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
81
CDTX
Cidara Therapeutics
Last Price:
20.68
Seasonality Move:
12.66%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing selling pressure, which indicates risk of future bearish movement.
Cidara Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.92 | Buy |
| 20-day SMA: | 13.82 | Buy |
| 50-day SMA: | 12.13 | Buy |
| 200-day SMA: | 13.02 | Buy |
| 8-day EMA: | 15.2 | Buy |
| 20-day EMA: | 13.98 | Buy |
| 50-day EMA: | 12.84 | Buy |
| 200-day EMA: | 13.3 | Buy |
Cidara Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.09 | Buy |
| Relative Strength Index (14 RSI): | 81.41 | Buy |
| Chaikin Money Flow: | -360175 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.84 - 14.78) | Buy |
| Bollinger Bands (100): | (10.93 - 13.39) | Buy |
Cidara Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cidara Therapeutics Stock
Is Cidara Therapeutics Stock a Buy?
- Cidara Therapeutics share price is 17.45 while CDTX 8-day simple moving average is 14.92, which is a Buy signal.
- The stock price of CDTX is 17.45 while Cidara Therapeutics 20-day SMA is 13.82, which makes it a Buy.
- Cidara Therapeutics 50-day simple moving average is 12.13 while CDTX share price is 17.45, making it a Buy technically.
- CDTX stock price is 17.45 and Cidara Therapeutics 200-day simple moving average is 13.02, creating a Buy signal.
CDTX Technical Analysis vs Fundamental Analysis
Buy
81
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy or a Sell?
-
Cidara Therapeutics stock is rated a Buy
The current Cidara Therapeutics [CDTX] share price is $17.45. The Score for CDTX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
Cidara Therapeutics Stock Info
Market Cap:
122.96M
Price in USD:
17.45
Share Volume:
450.94K
Cidara Therapeutics 52-Week Range
52-Week High:
24.40
52-Week Low:
10.00
Buy
81
Cidara Therapeutics (CDTX)
is a Buy
Cidara Therapeutics Share Price Forecast
-
What is the Cidara Therapeutics stock price today?
The Cidara Therapeutics stock price is 17.45 USD today. -
Will CDTX stock go up or go down?
Cidara Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cidara Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cidara Therapeutics is not overvalued.
Is Cidara Therapeutics Stock a Buy?
- Cidara Therapeutics share price is 17.45 while CDTX 8-day exponential moving average is 15.20, which is a Buy signal.
- The stock price of CDTX is 17.45 while Cidara Therapeutics 20-day EMA is 13.98, which makes it a Buy.
- Cidara Therapeutics 50-day exponential moving average is 12.84 while CDTX share price is 17.45, making it a Buy technically.
- CDTX stock price is 17.45 and Cidara Therapeutics 200-day simple moving average is 13.30, creating a Buy signal.
Fundamental Analysis of Cidara Therapeutics
Is Cidara Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $1.97 per share, a decrease next quarter of $0.00 per share, a decrease this year of $18.96 per share, and an increase next year of $15.14 per share.
Technical Analysis of Cidara Therapeutics
Should I short Cidara Therapeutics stock?
- CDTX Moving Average Covergence Divergence (MACD) indicator is 1.09, suggesting Cidara Therapeutics is a Buy
- Cidara Therapeutics Relative Strength Index (RSI) is 81.41, which suggest Cidara Therapeutics is overbought
- The Bollinger Bands (25) for Cidara Therapeutics is (11.84 - 14.78), which suggest Cidara Therapeutics is a Buy
- The Bollinger Bands (100) for Cidara Therapeutics is (10.93 - 13.39), which suggest Cidara Therapeutics is a Buy
* Cidara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.